Purpurin

Details

Top
Internal ID 16826047-1cb8-4e98-aa05-ef0d772c2bb6
Taxonomy Benzenoids > Anthracenes > Anthraquinones > Hydroxyanthraquinones
IUPAC Name 1,2,4-trihydroxyanthracene-9,10-dione
SMILES (Canonical) C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O
SMILES (Isomeric) C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O
InChI InChI=1S/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19H
InChI Key BBNQQADTFFCFGB-UHFFFAOYSA-N
Popularity 803 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H8O5
Molecular Weight 256.21 g/mol
Exact Mass 256.03717335 g/mol
Topological Polar Surface Area (TPSA) 94.80 Ų
XlogP 2.90
Atomic LogP (AlogP) 1.58
H-Bond Acceptor 5
H-Bond Donor 3
Rotatable Bonds 0

Synonyms

Top
81-54-9
Verantin
1,2,4-Trihydroxyanthraquinone
Hydroxylizaric acid
Purpurine
1,2,4-trihydroxyanthracene-9,10-dione
Smoke Brown G
1,2,4-Trihydroxy-9,10-anthracenedione
1,2,4-Trihydroxy-9,10-anthraquinone
1,2,4-Trihydroxyanthrachinon
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Purpurin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9440 94.40%
Caco-2 - 0.7297 72.97%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability + 0.7571 75.71%
Subcellular localzation Mitochondria 0.6168 61.68%
OATP2B1 inhibitior - 0.6989 69.89%
OATP1B1 inhibitior + 0.9414 94.14%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.8835 88.35%
P-glycoprotein inhibitior - 0.9352 93.52%
P-glycoprotein substrate - 0.9760 97.60%
CYP3A4 substrate - 0.6778 67.78%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8234 82.34%
CYP3A4 inhibition - 0.7561 75.61%
CYP2C9 inhibition - 0.5531 55.31%
CYP2C19 inhibition - 0.9382 93.82%
CYP2D6 inhibition - 0.8606 86.06%
CYP1A2 inhibition + 0.7851 78.51%
CYP2C8 inhibition - 0.9285 92.85%
CYP inhibitory promiscuity - 0.7853 78.53%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8875 88.75%
Carcinogenicity (trinary) Non-required 0.4953 49.53%
Eye corrosion - 0.9927 99.27%
Eye irritation + 0.9845 98.45%
Skin irritation + 0.7486 74.86%
Skin corrosion - 0.8518 85.18%
Ames mutagenesis + 0.9400 94.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8667 86.67%
Micronuclear + 0.8400 84.00%
Hepatotoxicity + 0.7750 77.50%
skin sensitisation + 0.5730 57.30%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity - 0.6556 65.56%
Mitochondrial toxicity + 0.5750 57.50%
Nephrotoxicity + 0.5307 53.07%
Acute Oral Toxicity (c) III 0.6165 61.65%
Estrogen receptor binding + 0.7995 79.95%
Androgen receptor binding + 0.7405 74.05%
Thyroid receptor binding - 0.5428 54.28%
Glucocorticoid receptor binding + 0.9421 94.21%
Aromatase binding + 0.7497 74.97%
PPAR gamma + 0.8343 83.43%
Honey bee toxicity - 0.9012 90.12%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9820 98.20%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 28183.8 nM
25118.9 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL3577 P00352 Aldehyde dehydrogenase 1A1 25118.9 nM
7079.5 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL3687 P18054 Arachidonate 12-lipoxygenase 3548.1 nM
Potency
via CMAUP
CHEMBL2903 P16050 Arachidonate 15-lipoxygenase 5011.9 nM
6309.6 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL1293236 P46063 ATP-dependent DNA helicase Q1 3981.1 nM
6309.6 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL5990 P38398 Breast cancer type 1 susceptibility protein 39810.7 nM
39810.7 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL4878 Q16678 Cytochrome P450 1B1 700 nM
Ki
via Super-PRED
CHEMBL340 P08684 Cytochrome P450 3A4 39810.7 nM
25118.9 nM
39810.7 nM
25118.9 nM
Potency
Potency
Potency
Potency
via CMAUP
via CMAUP
via CMAUP
via CMAUP
CHEMBL4159 Q99714 Endoplasmic reticulum-associated amyloid beta-peptide-binding protein 7943.3 nM
3162.3 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL1287622 Q9Y468 Lethal(3)malignant brain tumor-like protein 1 31622.8 nM
Potency
via CMAUP
CHEMBL1293226 B2RXH2 Lysine-specific demethylase 4D-like 15848.9 nM
22387.2 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL4040 P28482 MAP kinase ERK2 12589.3 nM
19952.6 nM
31622.8 nM
Potency
Potency
Potency
via CMAUP
via CMAUP
via CMAUP
CHEMBL3869 P50281 Matrix metalloproteinase 14 30600 nM
IC50
via CMAUP
CHEMBL1293224 P10636 Microtubule-associated protein tau 22387.2 nM
28183.8 nM
5011.9 nM
5011.9 nM
14125.4 nM
12589.3 nM
Potency
Potency
Potency
Potency
Potency
Potency
via CMAUP
via CMAUP
via CMAUP
via CMAUP
via CMAUP
via CMAUP
CHEMBL1951 P21397 Monoamine oxidase A 422 nM
Ki
via Super-PRED
CHEMBL1075138 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 316.2 nM
316.2 nM
Potency
Potency
via CMAUP
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.78% 91.11%
CHEMBL2581 P07339 Cathepsin D 95.92% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.94% 95.56%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 90.01% 99.15%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 89.28% 82.69%
CHEMBL1806 P11388 DNA topoisomerase II alpha 85.86% 89.00%
CHEMBL3401 O75469 Pregnane X receptor 85.04% 94.73%
CHEMBL2378 P30307 Dual specificity phosphatase Cdc25C 84.34% 96.67%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 82.66% 93.03%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 82.36% 99.23%
CHEMBL2535 P11166 Glucose transporter 80.62% 98.75%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.46% 86.33%

Cross-Links

Top
PubChem 6683
NPASS NPC238629
ChEMBL CHEMBL294264
LOTUS LTS0111755
wikiData Q116472